p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
By A. Villunger, Ewa M Michalak, Leigh Coultas, F. Müllauer, G. Böck, M. Ausserlechner, Jerry M. Adams, A. Strasser. Science, 2003
1,411 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/b729f9e1b738d10e7339b57fecf06586794bd576
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- A. Strasser
- Douglas R. Green
- Karen H. Vousden
- Eyal Gottlieb
- F. Llambi
- C. V. Dang
- Navdeep S. Chandel
- J. Wells
In Molecular Biology
- Jerry M. Adams
- Suzanne Cory
- A. Strasser
- Douglas R. Green
- Simon N. Willis
- H. Ahsan
- P. Czabotar
- M. S. Ola
In Oncology
- Jerry M. Adams
- A. Strasser
- Suzanne Cory
- Douglas R. Green
- Simon N. Willis
- K. Nakano
- Karen H. Vousden
- H. Ahsan
Citations in the corpus
- How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? (2017, background): “68,69 Interestingly, additional loss of the BH3-only protein BIM70,71 (i.e., combined loss of PUMA, NOXA plus BIM) provided as potent protection against nutlin-3a and etoposide as loss of p53 (Figure 2).68,69 After treatment with etoposide or nutlin-3a, BIM expression was upregulated inEμMyc lymphom”
- Radiation-induced cell death mechanisms (2010, background): “Additionally, Noxa [44, 46 ] and Bim [43] are other BH3-only proteins which contribute to radiation induced p53-dependent apoptosis.”
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. (2006, background): “, 2005), in part by p53-induced upregulation of Noxa (Shibue et al., 2003; Villunger et al., 2003).”
- TIGAR, a p53-inducible regulator of glycolysis and apoptosis. (2006, background): “, 1995), and the expression of the BH3-domain protein PUMA is an essential component of p53-activated apoptotic pathways in several cell types (Jeffers et al., 2003; Villunger et al., 2003).”
- The Bcl-2 apoptotic switch in cancer development and therapy (2007, background): “Importantly, the promiscuous binders (e.g. Bim and Puma) are much more potent killers than those that cannot engage all the pro-survival proteins, but the combination of Noxa and Bad potently induces cell death (Figure 2b; Chen et al., 2005).”
- Acetylation of the p53 DNA-binding domain regulates apoptosis induction. (2006, background): “In human cells, p53 requires both BAX and PUMA to efficiently induce apoptosis (Chipuk et al., 2003; Jeffers et al., 2003; Villunger et al., 2003; Yu et al., 2003; Zhang et al., 2000).”